MarketLupin launches generic hypertension drug in US after regulatory nod 7 Globe News1 hour ago1 hour ago01 mins Lupin has launched Azilsartan Medoxomil tablets in the US after securing FDA approval, becoming the exclusive first-to-file generic applicant and gaining 180 days of market exclusivity for the hypertension treatment. 2 Min Read Continue Reading (Edited by : Sheersh Kapoor) Source link Post navigation Previous: Madras high court says bad intention can’t be ruled out if church comes up close to temple, stays construction in Coimbatore | Chennai NewsNext: High Protein Fruits: This common fruit has more protein than most people realise and it’s probably in your kitchen Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment.
US Fed meeting today: 5 key things to watch on rates, inflation and growth – Markets 7 Globe News15 minutes ago15 minutes ago 0
NSE files DRHP for IPO; 14.89 cr shares on offer through OFS, LIC not participating 7 Globe News35 minutes ago35 minutes ago 0
NSE files DRHP for mega $2-3 billion IPO, 14.89 crore shares up for sale; SBI among key shareholders selling stakes – Markets 7 Globe News54 minutes ago54 minutes ago 0
Sensex Prediction for Thursday, June 18: Experts say ‘higher high-higher low’ pattern signals more upside; Will it break past 77500 resistance? – Markets 7 Globe News2 hours ago2 hours ago 0
